or Try an Advanced Search...

    Cancer Center Stocks List

    Symbol Grade Name % Change
    YMAB A Y-mAbs Therapeutics, Inc. 1.59
    TAK C Takeda Pharmaceutical Company Limited 0.14
    LIXT D Lixte Biotechnology Holdings, Inc. -4.27
    CYH D Community Health Systems, Inc. 3.70
    GLSI F Greenwich LifeSciences, Inc. -0.07
    ATNM F Actinium Pharmaceuticals, Inc. -5.00
    CLDX F Celldex Therapeutics, Inc. -1.46
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Cancer Treatment Immunology Immunotherapy Blastoma Brain Tumor Breast Cancer Clinical Development Clinical Medicine Kettering Cancer Center Medicine Memorial Sloan Monoclonal Antibodies Monoclonal Antibody Surgery Treatment Of Breast Cancer Treatment Of Cancer Acid

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Center stocks.

    Symbol Grade Name Weight
    PPH D Market Vectors Pharmaceutical ETF 4.43
    OZEM D Roundhill GLP-1 & Weight Loss ETF 1.96
    BBP A BioShares Biotechnology Products Fund 1.8
    GINX D SGI Enhanced Global Income ETF 1.74
    SBIO B ALPS Medical Breakthroughs ETF 1.64
    View all Cancer Center ETFs...
    Compare ETFs
    Compare BBP to GINX Compare GINX to SBIO Compare PPH to SBIO

        Cancer Center Stocks Recent News

        Date Stock Title
        Nov 1 YMAB Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know
        Nov 1 TAK Takeda Pharmaceutical Company Limited 2025 Q2 - Results - Earnings Call Presentation
        Nov 1 TAK Takeda Pharmaceutical Company Limited (TAK) Q2 2025 Earnings Call Transcript
        Oct 31 TAK HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda
        Oct 31 TAK Takeda Pharmaceutical reports H1 results, revises FY forecast
        Oct 31 TAK Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
        Oct 30 CYH Community Health Systems: Tough Q3 Stifles Recovery - Potentially Sets Up Contrarian Trade
        Oct 30 TAK Takeda Pharmaceutical FQ2 Earnings Preview
        Oct 29 CLDX Celldex selloff creates buying opportunity, says Guggenheim
        Oct 29 LIXT Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
        Oct 28 CLDX Celldex Therapeutics (NASDAQ:CLDX) pulls back 6.1% this week, but still delivers shareholders fantastic 57% CAGR over 5 years
        Oct 27 CYH Community Health Systems, Inc. (NYSE:CYH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
        Oct 27 CYH Supreme Court’s Chevron Overturn Spurs Regulatory Uncertainty for Community Health Systems
        Oct 26 CLDX Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
        Related Stock Lists: Cancer Biopharmaceutical Biotechnology Cancer Treatment Immunology Immunotherapy Blastoma Brain Tumor Breast Cancer Clinical Development Clinical Medicine Kettering Cancer Center Medicine Memorial Sloan Monoclonal Antibodies Monoclonal Antibody Surgery Treatment Of Breast Cancer Treatment Of Cancer Acid
        Cancer Center

        Cancer Center is a medical facility that specializes in the diagnosis, treatment, and prevention of cancer. It typically includes a team of specialists, such as oncologists, radiologists, surgeons, and other healthcare professionals, who work together to provide comprehensive care for cancer patients. Cancer Centers may also offer support services, such as counseling, nutrition, and rehabilitation, to help patients cope with the physical and emotional effects of cancer.

        Browse All Tags